With Congress out for a spring holiday, CMS decided to release some of the early Medicare rules and DC enjoyed one of the longest cherry blossom seasons on record (https://wapo.st/4cFlGLh)
As the end of Q1 fast approaches, we may finally have a funding deal… for this year. But do we have a Speaker?
This week featured publication of the long-awaited EtO Final Rule, more fallout from the Change Healthcare cyberattack, and PBM reform may not be dead…yet.
This week we focus on prescription drugs and the State of the Union while Change Healthcare’s outage continues on.
This week all eyes have been on Congress and their efforts to avert a partial (or total) government shutdown. Meanwhile, the EtO final rule (expected today) is still pending but the MA final rule is at OMB.
This week’s feature is my conversation with Peggy Tighe from Powers Law about the future of the Prior Auth Bill.
This Valentines week, healthcare took a backseat to other political matters of the heart on the Hill while regulators continue to shine a light on health equity and heart health during a month when we celebrate Black history and heart disease awareness. Meanwhile, healthcare industry reports for FY2023 continue trickle out. They paint an interesting picture – highlighting the influence of private equity, among others, in a changing landscape.
Drugs stay in the spotlight on the Hill and plans digest the new MA rules. CMR announcement jostles Republican leadership.
EVOQUE gets FDA approval, IRA drug negotiations kick off, and Aduhelm walks away from CED, and more!
CMS touts record marketplace enrollments, mental health and health equity achievements, promises TCET this year.
Copyright © 2022-2024 Savage Health Policy, LLC.
All rights reserved.
Recent Comments